Clostridium difficile infection and intestinal microbiota interactions

Microbial Pathogenesis

Volumn 89, Issue , 2015, Pages 201-209

  Rodriguez, C ^a   Taminiau, B ^a   Van Broeck, J ^b   Delmee M ^b   Daube, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Clostridium difficile; Colonisation; Infection; Intestinal microbiota

Indexed keywords

ARTIFICIAL MILK; BACTERIAL COLONIZATION; BREAST MILK; CLOSTRIDIUM DIFFICILE INFECTION; DONOR; FAECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFECTION RATE; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; REVIEW; SPECIES COMPOSITION; SPECIES RICHNESS; SUDDEN INFANT DEATH SYNDROME; TRANSPLANTATION; CLOSTRIDIUM INFECTION; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; ORGANISMAL INTERACTION;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIAL INTERACTIONS;

EID: 84947261334     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2015.10.018     Document Type: Review

References (107)

1. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
2. Simango C., Uladi S. Detection of Clostridium difficile diarrhoea in Harare, Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 2014, 108:354-357.
3. Deniz U., Ulger N., Aksu B., Karavuş M., Söyletir G. Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital. Mikrobiyol. Bülteni 2011, 45:1-10.
4. Balassiano I.T., Yates E.A., Domingues R.M.C.P., Ferreira E.O. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J. Med. Microbiol. 2012, 61(Pt 2):169-179.
5. Weese J.S., Finley R., Reid-Smith R.R., Janecko N., Rousseau J. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol. Infect. 2010, 138:1100-1104.
6. Schneeberg A., Rupnik M., Neubauer H., Seyboldt C. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe 2012, 18:484-488.
7. Båverud V., Gustafsson A., Franklin A., Aspán A., Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Veterinary J. 2003, 35:465-471.
8. Rodriguez C., Avesani V., Van Broeck J., Taminiau B., Delmée M., Daube G. Presence of Clostridium difficile in pigs and cattle intestinal contents and carcass contamination at the slaughterhouse in Belgium. Int. J. Food Microbiol. 2013, 166:256-262.
9. Jardine C.M., Reid-Smith R.J., Rousseau J., Weese J.S. Detection of Clostridium difficile in small and medium-sizised wild Mammals in Southern Ontario, Canada. J. Wildl. Dis. 2013, 49:418-421.
10. Al Saif N. Brazier JS: the distribution of Clostridium difficile in the environment of South Wales. J. Med. Microbiol. 1996, 45:133-137.
11. Zidaric V., Beigot S., Lapajne S., Rupnik M. The occurrence and high diversity of Clostridium difficile genotypes in rivers. Anaerobe 2010, 16:371-375.
12. Pasquale V., Romano V., Rupnik M., Capuano F., Bove D., Aliberti F., Krovacek K., Dumontet S. Occurrence of toxigenic Clostridium difficile in edible bivalve molluscs. Food Microbiol. 2012, 31:309-312.
13. Songer J.G., Trinh H.T., Killgore G.E., Thompson A.D., McDonald L.C., Limbago B.M. Clostridium difficile in retail meat products, USA, 2007. Emerg. Infect. Dis. 2009, (15):819-821.
14. Eckert C., Burghoffer B., Barbut F. Contamination of ready-to-eat raw vegetables with Clostridium difficile in France. J. Med. Microbiol. 2013, 62(Pt 9):1435-1438.
15. Squire M.M., Riley T.V. One Health: the Human-animal-environment Interfaces in Emerging Infectious Diseases 2013, Volume 365. Springer Berlin Heidelberg, Berlin, Heidelberg, (Current Topics in Microbiology and Immunology).
16. Goorhuis A., Debast S.B., van Leengoed L.A.M.G., Harmanus C., Notermans D.W., Bergwerff A.A., Kuijper E.J. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs?. J. Clin. Microbiol. 2008, 46:1157. author reply 1158.
17. Hensgens M.P.M., Keessen E.C., Squire M.M., Riley T.V., Koene M.G.J., de Boer E., Lipman L.J.A., Kuijper E.J. Clostridium difficile infection in the community: a zoonotic disease?. Clin. Microbiol. Infect.' Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2012, 18:635-645.
18. Cohen Stuart H., Gerding Dale N., Johnson Stuart, Kelly Ciaran P., Loo Vivian G., McDonald L.Clifford, Pepin Jacques, Wilcox Mark H. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) 2010.
19. Venugopal A.A., Gerding D.N., Johnson S. Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates. Am. J. Infect. Control 2011, 39:206-211.
20. Ghose C. Clostridium difficile infection in the twenty-first century. Emerg. Microbes Infect. 2013, 2:e62.
21. Banaei N., Anikst V., Schroeder L.F. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 2015, 372:2368-2370.
22. Hensgens M.P.M., Dekkers O.M., Demeulemeester A., Buiting A.G.M., Bloembergen P., van Benthem B.H.B., Le Cessie S., Kuijper E.J. Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study. Clin. Microbiol. Infect.' Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2014, 20:O1067-O1074.
23. Salazar M., Baskin L., Garey K.W., DuPont H.L. Clostridium difficile-related death rates in Texas 1999-2005. J. Infect. 2009, 59:303-307.
24. Dubberke E. Clostridium difficile infection: the scope of the problem. J. Hosp. Med. 2012, 7(Suppl. 3):S1-S4.
25. Asensio A., Di Bella S., Vecchio A.L., Grau S., Hart W.M., Isidoro B., Scotto R., Petrosillo N., Watt M., Nazir J. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study. Int. J. Infect. Dis.' IJID' Off. Publ. Int. Soc. Infect. Dis. 2015.
26. Seekatz A.M., Aas J., Gessert C.E., Rubin T.A., Saman D.M., Bakken J.S., Young V.B. Recovery of the gut microbiome following fecal microbiota transplantation. mBio 2014, 5. e00893-14.
27. Borriello S.P. The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann. Med. 1990, 22:61-67.
28. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6:130.
29. Heeg D., Burns D.A., Cartman S.T., Minton N.P. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PloS One 2012, 7:e32381.
30. Borriello S.P. 12th C. L. Oakley lecture. Pathogenesis of Clostridium difficile infection of the gut. J. Med. Microbiol. 1990, 33:207-215.
31. Drudy D., Fanning S., Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile. Int. J. Infect. Dis.' IJID' Off. Publ. Int. Soc. Infect. Dis. 2007, 11:5-10.
32. Gerding D.N., Johnson S., Rupnik M., Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 2014, 5:15-27.
33. Eckert C., Emirian A., Le Monnier A., Cathala L., De Montclos H., Goret J., Berger P., Petit A., De Chevigny A., Jean-Pierre H., Nebbad B., Camiade S., Meckenstock R., Lalande V., Marchandin H., Barbut F. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B. New Microbes New Infect. 2015, 3:12-17.
34. Gebhard R.L., Gerding D.N., Olson M.M., Peterson L.R., McClain C.J., Ansel H.J., Shaw M.J., Schwartz M.L. Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis. Am. J. Med. 1985, 78:45-48.
35. Jones A.M., Kuijper E.J., Wilcox M.H. Clostridium difficile: a European perspective. J. Infect. 2013, 66:115-128.
36. Olsen M.A., Yan Y., Reske K.A., Zilberberg M.D., Dubberke E.R. Recurrent Clostridium difficile infection is associated with increased mortality. Clin. Microbiol. Infect.' Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2015, 21:164-170.
37. Kelly C.P., LaMont J.T. Clostridium difficile infection. Annu. Rev. Med. 1998, 49:375-390.
38. Gerding D.N., Olson M.M., Peterson L.R., Teasley D.G., Gebhard R.L., Schwartz M.L., Lee J.T. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch. Intern. Med. 1986, 146:95-100.
39. Shankar V., Hamilton M.J., Khoruts A., Kilburn A., Unno T., Paliy O., Sadowsky M.J. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2014, 2:13.
40. Altman K.W., Chhaya V., Hammer N.D., Pavlova S., Vesper B.J., Tao L., Radosevich J.A. Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains. Laryngoscope 2008, 118:599-604.
41. Dial S., Alrasadi K., Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrheadiarrhoea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004, 171:33-38.
42. Woodmansey E.J. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007, 102:1178-1186.
43. Kyne L., Merry C., O'Connell B., Kelly A., Keane C., O'Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999, 28:107-113.
44. Avershina E., Rudi K. Confusion about the species richness of human gut microbiota. Benef. Microbes 2015, 1-4.
45. Theriot C.M., Young V.B. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes 2014, 5:86-95.
46. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Sci. (New York, NY) 2006, 312:1355-1359.
47. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Sci. (New York, NY) 2005, 308:1635-1638.
48. Hayashi H., Sakamoto M., Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol. Immunol. 2002, 46:535-548.
49. Wang Y., Qian P.-Y. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PloS One 2009, 4:e7401.
50. Ferreira R.B.R., Gill N., Willing B.P., Antunes L.C.M., Russell S.L., Croxen M.A., Finlay B.B. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PloS One 2011, 6:e20338.
51. Macfarlane G.T., Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Int. 2012, 95:50-60.
52. Hopkins M.J., Macfarlane G.T. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 2002, 51:448-454.
53. Hague A., Singh B., Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 1997, 112:1036-1040.
54. Guilloteau P., Martin L., Eeckhaut V., Ducatelle R., Zabielski R., Van Immerseel F. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr. Res. Rev. 2010, 23:366-384.
55. Zhang L., Dong D., Jiang C., Li Z., Wang X., Peng Y. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonizisation. Anaerobe 2015, 34:1-7.
56. Duncan S.H., Louis P., Flint H.J. Lactate-utilizising bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 2004, 70:5810-5817.
57. Shahinas D., Silverman M., Sittler T., Chiu C., Kim P., Allen-Vercoe E., Weese S., Wong A., Low D.E., Pillai D.R. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio 2012, 3.
58. Antonopoulos D.A., Huse S.M., Morrison H.G., Schmidt T.M., Sogin M.L., Young V.B. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 2009, 77:2367-2375.
59. Vrieze A., Out C., Fuentes S., Jonker L., Reuling I., Kootte R.S., van Nood E., Holleman F., Knaapen M., Romijn J.A., Soeters M.R., Blaak E.E., Dallinga-Thie G.M., Reijnders D., Ackermans M.T., Serlie M.J., Knop F.K., Holst J.J., van der Ley C., Kema I.P., Zoetendal E.G., de Vos W.M., Hoekstra J.B.L., Stroes E.S., Groen A.K., Nieuwdorp M. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatology 2014, 60:824-831.
60. Newton D.F., Macfarlane S., Macfarlane G.T. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob. Agents Chemother. 2013, 57:2016-2025.
61. Vincent C., Stephens D.A., Loo V.G., Edens T.J., Behr M.A., Dewar K., Manges A.R. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome 2013, 1:18.
62. Ozaki E., Kato H., Kita H., Karasawa T., Maegawa T., Koino Y., Matsumoto K., Takada T., Nomoto K., Tanaka R., Nakamura S. Clostridium difficile colonizisation in healthy adults: transient colonizisation and correlation with enterococcal colonizisation. J. Med. Microbiol. 2004, 53(Pt 2):167-172.
63. Rodriguez-Palacios A., Pickworth C., Loerch S., LeJeune J.T. Transient fecal shedding and limited animal-to-animal transmission of Clostridium difficile by naturally infected finishing feedlot cattle. Appl. Environ. Microbiol. 2011, 77:3391-3397.
64. Kato H., Kita H., Karasawa T., Maegawa T., Koino Y., Takakuwa H., Saikai T., Kobayashi K., Yamagishi T., Nakamura S. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J. Med. Microbiol. 2001, 50:720-727.
65. Mitsuoka T., Hayakawa K., Kimura N. [The faecal flora of man. II. The composition of bifidobacterium flora of different age groups (author's transl)]. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene Erste Abteilung Originale Reihe A. Med. Mikrobiol. Parasitol. 1974, 226:469-478.
66. Al-Jumaili I.J., Shibley M., Lishman A.H., Record C.O. Incidence and origin of Clostridium difficile in neonates. J. Clin. Microbiol. 1984, 19:77-78.
67. Rea M.C., O'Sullivan O., Shanahan F., O'Toole P.W., Stanton C., Ross R.P., Hill C. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J. Clin. Microbiol. 2012, 50:867-875.
68. Delmée M., Verellen G., Avesani V., Francois G. Clostridium difficile in neonates: serogrouping and epidemiology. Eur. J. Pediatr. 1988, 147:36-40.
69. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L.P., Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis.' Off. Publ. Infect. Dis. Soc. Am. 2007, 45:992-998.
70. Ziakas P.D., Zacharioudakis I.M., Zervou F.N., Grigoras C., Pliakos E.E., Mylonakis E. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PloS One 2015, 10:e0117195.
71. Jangi S., Lamont J.T. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J. Pediatr. Gastroenterol. Nutr. 2010, 51:2-7.
72. Rousseau C., Poilane I., De Pontual L., Maherault A.-C., Le Monnier A., Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin. Infect. Dis.' Off. Publ. Infect. Dis. Soc. Am. 2012, 55:1209-1215.
73. O'Toole H. Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis. Child. 1935, 49.
74. Larson H.E., Barclay F.E., Honour P., Hill I.D. Epidemiology of Clostridium difficile in infants. J. Infect. Dis. 1982, 146:727-733.
75. Bolton R.P., Tait S.K., Dear P.R., Losowsky M.S. Asymptomatic neonatal colonisation by Clostridium difficile. Arch. Dis. Child. 1984, 59:466-472.
76. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
77. Faden H.S., Dryja D. Importance of asymptomatic shedding of Clostridium difficile in environmental contamination of a neonatal intensive care unit. Am. J. Infect. Control 2015.
78. Martirosian G., Kuipers S., Verbrugh H., van Belkum A., Meisel-Mikolajczyk F. PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J. Clin. Microbiol. 1995, 33:2016-2021.
79. Sherertz R.J., Sarubbi F.A. The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizising enterocolitis and an asymptomatic group. J. Pediatr. 1982, 100:435-439.
80. Azad M.B., Konya T., Maughan H., Guttman D.S., Field C.J., Chari R.S., Sears M.R., Becker A.B., Scott J.A., Kozyrskyj A.L. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013, 185:385-394.
81. Fouhy F., Ross R.P., Fitzgerald G.F., Stanton C., Cotter P.D. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 2012, 3:203-220.
82. Biasucci G., Rubini M., Riboni S., Morelli L., Bessi E., Retetangos C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum. Dev. 2010, 86(Suppl. 1):13-15.
83. Furuichi M., Imajo E., Sato Y., Tanno S., Kawada M., Sato S. Characteristics of Clostridium difficile colonizisation in Japanese children. J. Infect. Chemother.' Off. J. Jpn. Soc. Chemother. 2014, 20:307-311.
84. Stark P.L., Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 1982, 15:189-203.
85. Rolfe R.D., Song W. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. J. Med. Microbiol. 1995, 42:10-19.
86. Kleessen B., Bunke H., Tovar K., Noack J., Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr. (Oslo, Nor.' 1992) 1995, 84:1347-1356.
87. Trejo F.M., Minnaard J., Perez P.F., De Antoni G.L. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006, 12:186-193.
88. Kato H., Kato N., Watanabe K., Ueno K., Ushijima H., Hashira S., Abe T. Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J. Clin. Microbiol. 1994, 32:2067-2070.
89. Rousseau C., Lemée L., Le Monnier A., Poilane I., Pons J.-L., Collignon A. Prevalence and diversity of Clostridium difficile strains in infants. J. Med. Microbiol. 2011, 60(Pt 8):1112-1118.
90. Camorlinga-Ponce M., Gamboa M., Barragan J.J., Munoz O., Fekety F.R., Torres J.F. Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrheal disease. Eur. J. Clin. Microbiol. 1987, 6:542-546.
91. Adlerberth I., Huang H., Lindberg E., Åberg N., Hesselmar B., Saalman R., Nord C.E., Wold A.E., Weintraub A. Toxin-producing Clostridium difficile strains as long-term gut colonizisers in healthy infants. J. Clin. Microbiol. 2014, 52:173-179.
92. Rousseau C., Levenez F., Fouqueray C., Doré J., Collignon A., Lepage P. Clostridium difficile colonizisation in early infancy is accompanied by changes in intestinal microbiota composition. J. Clin. Microbiol. 2011, 49:858-865.
93. Naaber P., Klaus K., Sepp E., Björksten B., Mikelsaar M. Colonizisation of infants and hospitalizised patients with Clostridium difficile and lactobacilli. Clin. Infect. Dis.' Off. Publ. Infect. Dis. Soc. Am. 1997, 25(Suppl. 2):S189-S190.
94. Naaber P., Smidt I., Stsepetova J., Brilene T., Annuk H., Mikelsaar M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol. 2004, 53(Pt 6):551-554.
95. Highet A.R., Berry A.M., Bettelheim K.A., Goldwater P.N. Gut microbiome in sudden infant death syndrome (SIDS) differs from that in healthy comparison babies and offers an explanation for the risk factor of prone position. Int. J. Med. Microbiol.' IJMM 2014, 304:735-741.
96. Crogan N.L., Evans B.C. Clostridium difficile: an emerging epidemic in nursing homes. Geriatr. Nurs. (New York, NY) 2007, 28:161-164.
97. Miller M., Gravel D., Mulvey M., Taylor G., Boyd D., Simor A., Gardam M., McGeer A., Hutchinson J., Moore D., Kelly S. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin. Infect. Dis.' Off. Publ. Infect. Dis. Soc. Am. 2010, 50:194-201.
98. Boone J.H., Archbald-Pannone L.R., Wickham K.N., Carman R.J., Guerrant R.L., Franck C.T., Lyerly D.M. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. Eur. J. Clin. Microbiol. Infect. Dis.' Off. Publ. Eur. Soc. Clin. Microbiol. 2014, 33:1045-1051.
99. Mylotte J.M., Russell S., Sackett B., Vallone M., Antalek M. Surveillance for Clostridium difficile infection in nursing homes. J. Am. Geriatr. Soc. 2013, 61:122-125.
100. Hopkins M.J., Sharp R., Macfarlane G.T. Variation in human intestinal microbiota with age. Dig. Liver Dis.' Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 2002, 34(Suppl. 2):S12-S18.
101. Gorbach S.L., Nahas L., Lerner P.I., Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 1967, 53:845-855.
102. Ito Y., Moriwaki H., Muto Y., Kato N., Watanabe K., Ueno K. Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile. J. Med. Microbiol. 1997, 46:80-84.
103. Gaskins H.R., Mackie R.I., May T., Garleb K.A. Dietary fructo-oligosaccharide modulates large intestinal inflammatory responses to Clostridium difficile in antibiotic-compromised mice. Microb. Ecol. Health & Dis. 1996, 9.
104. Evans C.T., Johnson S. Prevention of Clostridium difficile infection with probiotics. Clin. Infect. Dis.' Off. Publ. Infect. Dis. Soc. Am. 2015, 60(Suppl. 2):S122-S128.
105. Chang J.Y., Antonopoulos D.A., Kalra A., Tonelli A., Khalife W.T., Schmidt T.M., Young V.B. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 2008, 197:435-438.
106. Manges A.R., Labbe A., Loo V.G., Atherton J.K., Behr M.A., Masson L., Tellis P.A., Brousseau R. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J. Infect. Dis. 2010, 202:1877-1884.
107. Antharam V.C., Li E.C., Ishmael A., Sharma A., Mai V., Rand K.H., Wang G.P. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 2013, 51:2884-2892.